— Know what they know.
Not Investment Advice

LSL.V TSXV

LSL Pharma Group Inc
1W: -13.8% 1M: -16.4% YTD: -16.4%
C$0.29 ($0.21)
+0.01 (+1.72%)
 
Weekly Expected Move ±6.4%
C$0 C$0 C$0 C$0 C$0
TSXV · Healthcare · Medical - Pharmaceuticals · Tech Score Strong Sell · Power 37 · C$37.4M mcap · 95M float · 0.064% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapC$37.4M ($26.2M)
52W Range0.28-0.56
Volume83,760
Avg Volume60,677
Beta-0.37
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOFrançois Roberge
Employees252
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2023-03-02
540, d’Avaugour Street
Boucherville, QC J4B 0G6
CA
About LSL Pharma Group Inc

LSL Pharma Group, Inc. operates as a pharmaceutical company. It specializes in the development, manufacture and distribution of natural health products and dietary supplements in solid dosage forms as well as sterile ophthalmic pharmaceutical products. The company was founded on July 12, 2010 and is headquartered in Boucherville, Canada.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms